Adicet Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET) announced its participation in two virtual investor conferences in September 2021. The first is the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, where attendees can access a recorded presentation starting September 13 at 7:00 AM ET. The second event is the 2021 Cantor Virtual Global Healthcare Conference, featuring a fireside chat by CEO Chen Schor on September 27 at 10:00 AM ET. Live and archived audio webcasts will be available on Adicet Bio’s investor website.

MENLO PARK, Calif. and BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in two upcoming virtual investor conferences in September.

Details of the events are as follows:

H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021
Registered attendees can access the recorded presentation on-demand starting September 13, 2021 at 7:00 AM ET for the duration of the conference.

2021 Cantor Virtual Global Healthcare Conference, September 27-30, 2021
Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on Monday, September 27, 2021 at 10:00 AM ET.

Live audio webcasts of the of the presentation and fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. Archived replays will be available for 30 days following the presentations.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts

Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com

FAQ

What events will Adicet Bio (ACET) participate in September 2021?

Adicet Bio will participate in the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15 and the 2021 Cantor Virtual Global Healthcare Conference from September 27-30.

When can I access the recorded presentation from the H.C. Wainwright conference?

The recorded presentation will be available on-demand starting September 13, 2021, at 7:00 AM ET.

Who is the speaker at the Cantor Virtual Global Healthcare Conference for Adicet Bio?

Chen Schor, the President and CEO of Adicet Bio, will participate in a fireside chat on September 27, 2021, at 10:00 AM ET.

Where can I find the live audio webcasts for Adicet Bio's presentations?

Live audio webcasts can be accessed on the Investors section of Adicet Bio’s website.

How long will the archived replays of Adicet Bio's presentations be available?

Archived replays will be available for 30 days following the presentations.